Sorin gets offer for renal care business

Italy's Sorin Group says that it has received an offer for the acquisition of its renal care business and has granted exclusivity to an investment consortium led by Argos Soditic, an independent European private equity firm, and MPS Venture SGR, for the purpose of finalizing negotiations. Completion of the transaction is subject to conditions including finalization of regulatory procedures for anti-trust and with employee representatives of the renal care operations in Italy and in France.

Once the deal terms are finalized and approved by the Sorin board, the company will provide full financial details resulting from the transaction, including EBITDA margin expansion and net debt reduction.

Will focus on core cardiovascular franchise